Dr. Lal Pathlabs Q1 FY27 Results: Net Profit ₹165.9 Cr, Up 28.3% YoY
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹629.6 Cr (+4.7% YoY) and net profit of ₹165.9 Cr (+28.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹165.9 Cr · +28.3% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹629.6 Cr (+4.7% YoY) and net profit of ₹165.9 Cr (+28.3% YoY) for Q1 FY27.
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹797.7 Cr (+19.1% YoY) and net profit of ₹170.5 Cr (+27.2% YoY) for Q1 FY27.
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹702.7 Cr (+16.6% YoY) and net profit of ₹132.2 Cr (-15.0% YoY) for Q4 FY26.
Dr. Lal PathLabs Ltd. reported its FY26 audited results and recommended a final dividend of INR 4/- per share. The company also announced the 100% acquisition of Shahbazkers Diagnostic Centre for up to INR 20 Crore and the incorporation of a new subsidiary in Dubai to expand its diagnostic services footprint.
Dr. Lal Pathlabs Ltd reported net profit of ₹91.4 Cr (-6.8% YoY) for Q3 FY26.
Dr. Lal Pathlabs Ltd reported net profit of ₹91.4 Cr (-6.8% YoY) for Q3 FY26.